Inhibition of Mycoplasma pneumoniae growth by FDA-approved anticancer and antiviral nucleoside and nucleobase analogs

被引：0
|
作者：
Ren Sun
Liya Wang
机构：
[1] Swedish University of Agricultural Sciences,Department of Anatomy, Physiology, and Biochemistry
[2] The Biomedical Centre,undefined
来源：
BMC Microbiology | / 13卷
关键词：
Growth inhibition; 6-thioguanine; Trifluorothymidine; Hypoxanthine guanine phosphoribosyl transferase; Thymidine kinase;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
相关论文
共 50 条
  • [21] Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets
    Park, Su-Jin
    Yu, Kwang-Min
    Kim, Young-Il
    Kim, Se-Mi
    Kim, Eun-Ha
    Kim, Seong-Gyu
    Kim, Eun Ji
    Casel, Mark Anthony B.
    Rollon, Rare
    Jang, Seung-Gyu
    Lee, Min-Hyeok
    Chang, Jae-Hyung
    Song, Min-Suk
    Jeong, Hye Won
    Choi, Younho
    Chen, Weiqiang
    Shin, Woo-Jin
    Jung, Jae U.
    Choi, Young Ki
    MBIO, 2020, 11 (03):
  • [22] Exploring the antiviral activities of the FDA-approved drug sulfadoxine and its derivatives against Chikungunya virus
    Martins, Daniel Oliveira Silva
    Ruiz, Uriel Enrique Aquino
    Santos, Igor Andrade
    Oliveira, Igor Santos
    Guevara-Vega, Marco
    de Paiva, Raphael Enoque Ferraz
    Abbehausen, Camilla
    Sabino-Silva, Robinson
    Corbi, Pedro Paulo
    Jardim, Ana Carolina Gomes
    PHARMACOLOGICAL REPORTS, 2024, 76 (05) : 1147 - 1159
  • [23] ILP-2 modeling and virtual screening of an FDA-approved library: a possible anticancer therapy
    Khalili, Saeed
    Mohammadpour, Hemn
    Shokrollahi Barough, Mahideh
    Kokhaei, Parviz
    TURKISH JOURNAL OF MEDICAL SCIENCES, 2016, 46 (04) : 1135 - 1143
  • [24] Chemical Diversity of Metabolites from Fungi, Cyanobacteria, and Plants Relative to FDA-Approved Anticancer Agents
    El-Elimat, Tamam
    Zhang, Xiaoli
    Jarjoura, David
    Moy, Franklin J.
    Orjala, Jimmy
    Kinghorn, A. Douglas
    Pearce, Cedric J.
    Oberlies, Nicholas H.
    ACS MEDICINAL CHEMISTRY LETTERS, 2012, 3 (08): : 645 - 649
  • [25] TIDieR checklist evaluation of clinical trial intervention reporting for recent FDA-approved anticancer medications
    Wayant, Cole
    Bindernagel, Richard
    Vassar, Matt
    BMJ EVIDENCE-BASED MEDICINE, 2020, 25 (03) : 97 - 101
  • [26] Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs
    Marcelletti, JF
    ANTIVIRAL RESEARCH, 2002, 56 (02) : 153 - 166
  • [27] Targeting the β-clamp in Helicobacter pylori with FDA-approved drugs reveals micromolar inhibition by diflunisal
    Pandey, Preeti
    Verma, Vijay
    Gautam, Gunjan
    Kumari, Nilima
    Dhar, Suman Kumar
    Gourinath, Samudrala
    FEBS LETTERS, 2017, 591 (15): : 2311 - 2322
  • [28] Recent Patents and FDA-Approved Drugs Based on Antiviral Peptides and Other Peptide-Related Antivirals
    Masoumeh Sadat Mousavi Maleki
    Soroush Sardari
    Ali Ghandehari Alavijeh
    Hamid Madanchi
    International Journal of Peptide Research and Therapeutics, 29
  • [29] Recent Patents and FDA-Approved Drugs Based on Antiviral Peptides and Other Peptide-Related Antivirals
    Maleki, Masoumeh Sadat Mousavi
    Sardari, Soroush
    Alavijeh, Ali Ghandehari
    Madanchi, Hamid
    INTERNATIONAL JOURNAL OF PEPTIDE RESEARCH AND THERAPEUTICS, 2022, 29 (01)
  • [30] Screening a Library of FDA-Approved and Bioactive Compounds for Antiviral Activity against SARS-CoV-2
    Biering, Scott B.
    Van Dis, Erik
    Wehri, Eddie
    Yamashiro, Livia H.
    Nguyenla, Xammy
    Dugast-Darzacq, Claire
    Graham, Thomas G. W.
    Stroumza, Julien R.
    Golovkine, Guillaume R.
    Roberts, Allison W.
    Fines, Daniel M.
    Spradlin, Jessica N.
    Ward, Carl C.
    Bajaj, Teena
    Dovala, Dustin
    Schulze-Gamen, Ursula
    Bajaj, Ruchika
    Fox, Douglas M.
    Ott, Melanie
    Murthy, Niren
    Nomura, Daniel K.
    Schaletzky, Julia
    Stanley, Sarah A.
    ACS INFECTIOUS DISEASES, 2021, 7 (08): : 2337 - 2351
12345